Skip to content
Screener

Arrowhead Research ARWR Interest Income

Interest Income at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$20.23M-18.1%
ALN
Alnylam PharmaceuticalsALNY
$28.14M+2.4%
Assembly Biosciences logo
Assembly BiosciencesASMB
$2.29M+104%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$815K-31.9%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$5M-16.7%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$8.76M+23.3%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterestAndDividend.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025Six Months Ended March 31, 2026Six Months Ended March 31, 2025
Total operating expenses214,997161,507438,221325,419
Operating (loss) income(141,260)381,202(100,451)219,790
Other income (expense):
Interest income16,8699,61526,56017,217
Interest expense(23,846)(21,639)(46,351)(43,285)
Loss on equity method investment(6,719)(6,719)
Gain on VIE's sale of IPR&D assets19,00019,000
Other, net(1,609)438(1,332)779

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's interest income?
Arrowhead Research (ARWR) reported interest income of $16.87M in Q1 2026.
How has Arrowhead Research's interest income changed year-over-year?
Arrowhead Research's interest income increased by 75.4% year-over-year, from $9.62M to $16.87M.
What is the long-term trend for Arrowhead Research's interest income?
Over 4 years (2021 to 2025), Arrowhead Research's interest income has grown at a 57.1% compound annual growth rate (CAGR), from $6.12M to $37.29M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Ask your AI about Arrowhead Research's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude